Latest Follistatin Stories
CLEVELAND and COLUMBUS, Ohio, Dec.
COLUMBUS, Ohio, Nov. 17, 2014 /PRNewswire/ -- The International Duchenne Alliance announced today that it will allocate $500,000 to Jerry Mendell, M.D.
CLEVELAND and COLUMBUS, Ohio, Oct.
Dr. Jerry Mendell Leading Follistatin Gene Therapy MIDDLETOWN, Ohio, Aug.
A study appearing in Science Translational Medicine puts scientists one step closer to clinical trials to test a gene delivery strategy to improve muscle mass and function in patients with certain degenerative muscle disorders.
There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA. The new therapy enhanced muscle strength, improved gross motor skills and increased the lifespan in a SMA model.
- A political dynamiter.